Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000173348 | SCV000170653 | benign | not specified | 2013-08-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000173348 | SCV000224448 | benign | not specified | 2015-02-25 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000418299 | SCV000511133 | benign | not provided | 2017-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313724 | SCV000848494 | benign | Inborn genetic diseases | 2014-10-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000990934 | SCV000884218 | benign | Mitochondrial complex 1 deficiency, nuclear type 12 | 2022-10-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000418299 | SCV001109908 | benign | not provided | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990934 | SCV001142003 | likely benign | Mitochondrial complex 1 deficiency, nuclear type 12 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000173348 | SCV001476565 | benign | not specified | 2019-10-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000990934 | SCV002803042 | likely benign | Mitochondrial complex 1 deficiency, nuclear type 12 | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000418299 | SCV005206734 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000030653 | SCV000053331 | uncertain significance | Mitochondrial complex I deficiency | 2011-08-01 | no assertion criteria provided | literature only | |
Genome |
RCV000030653 | SCV000607064 | not provided | Mitochondrial complex I deficiency | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Mayo Clinic Laboratories, |
RCV000418299 | SCV000802917 | uncertain significance | not provided | 2016-02-24 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000418299 | SCV001740040 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000173348 | SCV001798846 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000418299 | SCV001927274 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003924870 | SCV004751558 | benign | NDUFA1-related disorder | 2019-10-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |